Efficacy and Safety of Transcranial Direct Current Stimulation for Depression in Older Adults: A Systematic Review and Meta-Analysis of Mixed-Age Studies.
Isabel A Yoon, Caili Ren, Vanessa M Pazdernik, John Li, Sandeep R Pagali, Simon Kung, Annie M Waniger, Nick Corriveau-Lecavalier, Alvaro Pascual-Leone, Maria I Lapid
{"title":"Efficacy and Safety of Transcranial Direct Current Stimulation for Depression in Older Adults: A Systematic Review and Meta-Analysis of Mixed-Age Studies.","authors":"Isabel A Yoon, Caili Ren, Vanessa M Pazdernik, John Li, Sandeep R Pagali, Simon Kung, Annie M Waniger, Nick Corriveau-Lecavalier, Alvaro Pascual-Leone, Maria I Lapid","doi":"10.1016/j.jagp.2025.06.009","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Geriatric depression is a significant public health burden and is challenging to treat. The current study aimed to examine the effectiveness of transcranial direct current stimulation (tDCS) as a nonpharmacologic intervention approach for depression in older adults.</p><p><strong>Methods: </strong>We performed a systematic review of 24 studies across 13 countries including a total of 1,277 participants. Excluding six studies with incomplete data, we performed a metaanalysis of 18 randomized clinical trials (RCTs) involving 912 patients (502 active tDCS, 410 sham control tDCS).</p><p><strong>Results: </strong>Results revealed a large effect size favouring active tDCS for depressive symptoms (SMD = -0.96, 95% CI -1.56 to -0.37), though with high heterogeneity (I<sup>2</sup> = 89%). Large effect sizes favouring active tDCS were demonstrated in clinician-administered depression measures (Hamilton Depression Rating Scale [HDRS], Montgomery-Åsberg Depression Rating Scale [MADRS], Cornell Scale for Depression in Dementia [CSDD]) as well as in self-report measures (Beck Depression Inventory [BDI], Zung Self-Rating Depression Scale [SDS]). Subgroup analyses showed a nonsignificant effect in studies focused solely on major depressive disorder (MDD) and a large, though preliminary, effect in studies limited to adults aged 65 and older.</p><p><strong>Conclusions: </strong>These findings suggest that tDCS may be a promising nonpharmacological treatment option for depression in older adults, particularly in the context of comorbid conditions. However, further high-quality research specifically targeting this population is needed to validate its efficacy and optimize treatment protocols.</p>","PeriodicalId":520785,"journal":{"name":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","volume":" ","pages":"1077-1094"},"PeriodicalIF":3.8000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jagp.2025.06.009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/20 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Geriatric depression is a significant public health burden and is challenging to treat. The current study aimed to examine the effectiveness of transcranial direct current stimulation (tDCS) as a nonpharmacologic intervention approach for depression in older adults.
Methods: We performed a systematic review of 24 studies across 13 countries including a total of 1,277 participants. Excluding six studies with incomplete data, we performed a metaanalysis of 18 randomized clinical trials (RCTs) involving 912 patients (502 active tDCS, 410 sham control tDCS).
Results: Results revealed a large effect size favouring active tDCS for depressive symptoms (SMD = -0.96, 95% CI -1.56 to -0.37), though with high heterogeneity (I2 = 89%). Large effect sizes favouring active tDCS were demonstrated in clinician-administered depression measures (Hamilton Depression Rating Scale [HDRS], Montgomery-Åsberg Depression Rating Scale [MADRS], Cornell Scale for Depression in Dementia [CSDD]) as well as in self-report measures (Beck Depression Inventory [BDI], Zung Self-Rating Depression Scale [SDS]). Subgroup analyses showed a nonsignificant effect in studies focused solely on major depressive disorder (MDD) and a large, though preliminary, effect in studies limited to adults aged 65 and older.
Conclusions: These findings suggest that tDCS may be a promising nonpharmacological treatment option for depression in older adults, particularly in the context of comorbid conditions. However, further high-quality research specifically targeting this population is needed to validate its efficacy and optimize treatment protocols.